+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

PS41Characteristics Associated with Statin Prescribing for Primary Prevention of Cardiovascular Disease Among People with Diabetes



PS41Characteristics Associated with Statin Prescribing for Primary Prevention of Cardiovascular Disease Among People with Diabetes



Journal of Epidemiology & Community Health 66(Suppl 1): A54.1-A54




(PDF emailed within 0-6 h: $19.90)

Accession: 064226784

Download citation: RISBibTeXText

DOI: 10.1136/jech-2012-201753.140


Related references

Statin prescribing for prevention of cardiovascular disease amongst people with severe mental illness: Cohort study in UK primary care. Schizophrenia Research, 2017

Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006-2008. Diabetic Medicine 31(6): 640-646, 2015

Statin-prescribing trends for primary and secondary prevention of cardiovascular disease. Canadian Family Physician Medecin de Famille Canadien 63(11): E495-E503, 2017

Statin prescribing for primary prevention of cardiovascular disease: a cross-sectional, observational study. British Journal of General Practice 65(637): E538-E544, 2015

Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis. Bmc Health Services Research 14(): 414-414, 2015

Predictors of cholesterol treatment discussions and statin prescribing for primary cardiovascular disease prevention in community health centers. Preventive Medicine 88(): 176-181, 2016

Rational of Current Practice of Prescribing Statin to Treat Dyslipidaemia as Primary Prevention of Coronary Heart Disease in Elderly People. 2013

Statin for the primary prevention of cardiovascular disease in patients with diabetes mellitus. Diabetes & Metabolism Journal 38(1): 32-34, 2014

Should a statin be routinely prescribed for primary prevention of cardiovascular disease in diabetes mellitus?. Canadian Medical Association Journal 171(8): 857-857, 2004

Population Impact & Efficiency of Benefit-Targeted Versus Risk-Targeted Statin Prescribing for Primary Prevention of Cardiovascular Disease. Journal of the American Heart Association 6(2), 2017

Primary prevention of cardiovascular disease with statin in type 2 diabetes mellitus: Is it time to change our strategy?. Medicina Clinica 142(8): 358-359, 2014

Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes. Indian Journal of Medical Research 138(4): 461-491, 2015

Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease. Circulation 133(16): 1574-1581, 2016

Should aspirin be used for the primary prevention of cardiovascular disease in people with diabetes?. Medical Journal of Australia 190(11): 614-615, 2009

Variation in prescribing of lipid-lowering medication in primary care is associated with incidence of cardiovascular disease and all-cause mortality in people with screen-detected diabetes: findings from the ADDITION-Denmark trial. Diabetic Medicine 31(12): 1577-1585, 2015